Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Mead

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
The sword of Damocles and the treatment of stage I seminomaTim Oliver, Graham Mead, Malcolm Mason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986Maria De Santis, Joaquim Bellmunt, Graham Mead, et al.
Clinical Genitourinary Cancer|August 18, 2018
Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell CancerHayley S McKenzie, Graham Mead, Robert Huddart, et al.
European Urology|December 4, 2014
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinomaThomas Geldart, John Chester, Angela Casbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986Maria De Santis, Joaquim Bellmunt, Graham Mead, et al.
BJU International|April 29, 2017
Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomyRobert A Huddart, Alison Birtle, Lauren Maynard, et al.
Clinical Lymphoma & Myeloma|September 1, 2009
Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimensJennifer L Kelly, Stephen R Toothaker, Lauren Ciminello, et al.
Investigational New Drugs|January 19, 2013
Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancerRobert Jones, Jacqueline Vuky, Tony Elliott, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
The sword of Damocles and the treatment of stage I seminomaTim Oliver, Graham Mead, Malcolm Mason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986Maria De Santis, Joaquim Bellmunt, Graham Mead, et al.
Clinical Genitourinary Cancer|August 18, 2018
Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell CancerHayley S McKenzie, Graham Mead, Robert Huddart, et al.
European Urology|December 4, 2014
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinomaThomas Geldart, John Chester, Angela Casbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986Maria De Santis, Joaquim Bellmunt, Graham Mead, et al.
BJU International|April 29, 2017
Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomyRobert A Huddart, Alison Birtle, Lauren Maynard, et al.
Clinical Lymphoma & Myeloma|September 1, 2009
Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimensJennifer L Kelly, Stephen R Toothaker, Lauren Ciminello, et al.
Investigational New Drugs|January 19, 2013
Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancerRobert Jones, Jacqueline Vuky, Tony Elliott, et al.
Pageof 2